- freely available
Int. J. Mol. Sci. 2010, 11(5), 2067-2078; doi:10.3390/ijms11052067
Abstract: Antinociceptive and anti-inflammatory activities of the ethanol extract from Annona muricata L. leaves were investigated in animal models. The extract delivered per oral route (p.o.) reduced the number of abdominal contortions by 14.42% (at a dose of 200 mg/kg) and 41.41% (400 mg/kg). Doses of 200 and 400 mg/kg (p.o) inhibited both phases of the time paw licking: first phase (23.67% and 45.02%) and the second phase (30.09% and 50.02%), respectively. The extract (p.o.) increased the reaction time on a hot plate at doses of 200 (30.77% and 37.04%) and 400 mg/kg (82.61% and 96.30%) after 60 and 90 minutes of treatment, respectively. The paw edema was reduced by the ethanol extract (p.o.) at doses of 200 (23.16% and 29.33%) and 400 mg/kg (29.50% and 37.33%) after 3 to 4 h of application of carrageenan, respectively. Doses of 200 and 400 mg/kg (p.o.), administered 4 h before the carrageenan injection, reduced the exudate volume (29.25 and 45.74%) and leukocyte migration (18.19 and 27.95%) significantly. These results suggest that A. muricata can be an active source of substances with antinociceptive and anti-inflammatory activities.
Annona muricata L. (Annonaceae), commonly known as soursop, is found from Central America to South America, including the North, Northeast and Southeast regions of Brazil [1,2]. Traditionally, the leaves are used for headaches, insomnia, cystitis, liver problems, diabetes, hypertension and as an anti-inflammatory, antispasmodic and antidysenteric [1,2]. The decoction of the leaves have parasiticide, antirheumatic and antineuralgic effects when used internally, while the cooked leaves, applied topically, fight rheumatism and abscesses [1–3].
Among the chemical constituents found in A. muricata, the alkaloids (reticulin, coreximine, coclarine and anomurine) [4,5] and essential oils (β-caryophyllene, δ-cadinene, epi-α-cadinol and α-cadinol) [6,7] stand out. However, species of the Annonaceae family, including A. muricata, have also been targeted for investigation due to appurtenant substances in the acetogenins class  that have been isolated from different parts of the plant . For example, annomuricins A and B, gigantetrocin A, annonacin-10-one, muricatetrocins A and B, annonacin, goniothalamicin , muricatocins A and B, annonacin A, (2,4-trans)-isoannonacin, (2,4-cis)-isoannonacin , annomuricin C, muricatocin C, gigantetronenin , annomutacin, (2,4-trans)-10R-annonacin-A-one, (2,4-cis)-10R-annonacin-A-one , annopentocins A, B and C, cis- and trans-annomuricin-D-ones , annomuricine, muricapentocin , muricoreacin and murihexocin C  and annocatacin A and B  were identified in the leaves. These acetogenins have cytotoxic properties against tumor cell lines [10–17] and molluscicidal activity . In addition, A. muricata leaf extracts have antioxidant  and molluscicidal properties .
A. muricata ethnomedicinal use, especially for inflammation, rheumatism and neuralgy, still lacks scientifically supported pharmacological and clinical validation. In this sense, the aim of the present study was to investigate the antinociceptive and anti-inflammatory properties of the ethanol extract from A. muricata leaves using experimental animal models.
2. Results and Discussion
2.1. Acute Toxicity
At the doses administered per oral route (p.o.), the ethanol extract from A. muricata leaves was toxic to animals with LD50 of 1.67 g/kg (95% confidence intervals 1.24–2.26 g/kg). This result served as a parameter for dosage definition in the experiments of antinociceptive and anti-inflammatory activities.
2.2. Writhing Response Induced by Acetic Acid in Mice
Doses (p.o.) of 200 and 400 mg/kg of A. muricata extract significantly reduced (p < 0.01 and p < 0.001, respectively) the abdominal contortions induced by acetic acid to 57.87 ± 1.55 s and 39.62 ± 1.97 s compared to the respective control (67.62 ± 2.03 s) (Table 1).
2.3. Effects on Formalin-Induced Nociception in Mice
The intraplantar injection of formalin promoted a biphasic characteristic response (Table 2). The time spent licking in the first phase (0–5 min) was 86.62 ± 3.18 s and in the second phase (15–30 min) was 93.87 ± 2.73 s for the control group. After 60 min of treatment, doses (p.o.) of 200 and 400 mg/kg of extract significantly inhibited (p < 0.001) the first phase at 23.67 and 45.02% and the second phase at 30.09 and 50.20%, respectively, when compared to the control.
2.4. Effects on Hot-Plate Latency Assay in Mice
The A. muricata ethanol extract increased the latency time of mice exposed to the hot plate (Table 3). After 60 and 90 min of treatment, doses (p.o.) of 200 (30.77 and 37.04%) and 400 mg/kg (82.61 and 96.30%) increased significantly (p < 0.05 and p < 0.001, respectively) the latency time in the respective control group. Morphine proved to be a potent analgesic, increasing the latency time within the evaluation periods. Naloxone, an opioid antagonist, blocked the morphine action but did not completely alter the antinociceptive effect of the tested extracts.
2.5. Effects on Carrageenan-induced Edema in Rats
The A. muricata ethanol extract anti-inflammatory effect evaluated by the paw edema method induced by carrageenan is shown in Table 4. Edema inhibition was observed 3 h after carrageenan application of doses (p.o.) of 200 (0.73 ± 0.06; 23.16 %; p < 0.05) and 400 mg/kg (0.67 ± 0.04; 29.47 %; p < 0.01). 4 h after carrageenan injections, the doses of 200 (0.53 ± 0.03; p < 0.01) and 400 mg/kg (0.47 ± 0.02; p < 0.001) reduced the respective paw edema (29.33 and 37.33%). In this time, indomethacin also reduced the paw edema (42.67%).
2.6. Effects on Carrageenan-Induced Pleurisy in Rats
The pleurisy effects demonstrated that doses (p.o.) of 200 (p < 0.01) and 400 mg/kg (p < 0.001) of the extracts significantly reduced the exudate volume (Figure 1) and the number of total leukocytes (Figure 2). The exudate volume was decreased by 29.25 and 45.74% at doses (p.o.) of 200 and 400 mg/kg compared to the respective control. Leukocyte migration inhibition also occurred from doses (p.o.) of 200 (12.91 ± 0.32 × 103 cells/mm3; p < 0.001) and 400 mg/kg (11.37 ± 0.44 × 103 cells/mm3; p < 0.001). Indomethacin reduced the exudate volume and the leukocyte migration.
The acute toxicity test showed that the A. muricata leaves ethanol extract doses tested were toxic to mice. However, the largest dose administered (400 mg/kg) is less than the lowest dose applied for determination of the LD50 (0.5 g/kg or 500 mg/kg). Studies have demonstrated that isolated acetogenins from the A. muricata leaves are toxic to tumor cells [11–17] and molluscicides . It is possible that the toxic effect of the ethanol extract could be due to the presence of these substances. However, the pharmacological doses definition of the ethanol extract was not described in the literature. In the present study, the LD50 was used to define the doses that were administered to the animals.
Based on the pharmacological tests results, the A. muricata ethanol extract has antinociceptive and anti-inflammatory activities, being firstly reported in the literature. Intraperitoneal administration of acetic acid releases prostaglandins and sympathomimetic system mediators like PGE2 and PGF2α and their levels were increased in the peritoneal fluid of the acetic acid induced mice . Thus, the antinociceptive effect of the ethanol extract could be mediated by peripherical effects, including the prostaglandin synthesis inhibition. The antinociceptive effect was also demonstrated by the biphasic response time of paw licking induced by formalin . The first phase (0 to 5 min) corresponds to the neurogenic stage as an intensely painful process for the activation of nociceptive pathways, while inflammation mediators are produced after 15 minutes of formalin application (second phase) [22,23]. Substance P and bradykinin act as mediators in the first phase, while histamine, serotonin, prostaglandin and bradykinin are involved in the nociceptive response of the second stage . The central action was confirmed in the hot plate test (200 and 400 mg/kg), showing that the maximum effect is reached after 90 minutes. This test is considered to be sensitive to drugs acting at the supraspinal modulation level of the pain response , suggesting at least a modulatory effect of the extract. In this study, antinociceptive action did not depend entirely on the opioid system, because naloxone treatment did not completely reverse the produced effect [25,26]. The formalin induced algesia test also indicated a possible anti-inflammatory activity (the second phase was reduced from 200 mg/kg).
The anti-inflammatory activity was confirmed by the paw edema induced by carrageenan in rats, a model widely used to study anti-inflammatory substances. Carrageenan induces paw edema resulting in the release of mediators such as histamine, serotonin, bradykinin, substance P and a platelet activating factor and prostaglandins [27–33]. In this study, oral treatment with the A. muricata extract significantly inhibited the paw edema. This evidence suggests that the anti-inflammatory actions of the ethanol extract are related to inhibition of one or more signaling intracellular pathways involved with these mediators effects.
Pleurisy produced by intrapleural injection of carrageenan leads to the formation of exudate in the pleural cavity [34,35] and leukocyte migration [35,36]. It is a method that assesses the inflammatory infiltrate and confirms the obtained paw edema results. Non-steroidal anti-inflammatory drugs, such as indomethacin, inhibit the accumulation of exudates and mobilization of leukocytes between 3 and 6 h after application of carrageenan [35,37]. By reducing the volume of exudate and the leukocyte migration, the A. muricata ethanol extract confirmed the results of the paw edema (Table 4 and Figures 1 and 2).
Plants belonging to the Annonaceae family have been investigated for its antinociceptive and anti-inflammatory properties [25,26,38]. However, considering the compounds isolated from A. muricata, these properties are not been reported for the alkaloids [4,5] and acetogenins [8–18]. Antinociceptive and anti-inflammatory activities have been attributed to essential oil of Dennettia tripetala (Annonaceae) , but such activities are not described for the major components [6,7] identified in A. muricata. Additional studies are necessary to establish the possible correlation between activities and chemical composition of this plant.
3. Experimental Section
3.1. Plant Material and Extraction
The plant material used in this study was collected in Juiz de Fora, State of Minas Gerais, Brazil, in February 2008. The species was identified by Dr Fátima Regina Gonçalves Salimena and a voucher specimen (CESJ number 48236) was deposited in the Herbarium of the Universidade Federal de Juiz de Fora, Brazil. Dried and powdered leaves (600 g) were exhaustively extracted in 95% ethanol (2.5 L) by static maceration for 3 weeks at room temperature with renewal of solvent every 2 days. The ethanol extract was filtered and evaporated under a rotary evaporator at controlled temperature (50–60 °C). This material was placed in a desiccator with silica to yield 36.40 g. The dried extract was dissolved using 1% DMSO in normal saline for pharmacological studies.
Drugs and reagents used in this study (and their sources) were as follows: acetic acid (Vetec Química Farm Ltda, Rio de Janeiro, RJ, Brazil), formaldehyde (Reagen Quimibrás Ind. Química S.A., Rio de Janeiro, RJ, Brazil), morphine hydrochloride (Merck Inc., Whitehouse Station, NJ, USA), naloxone and indomethacin (Sigma Chemical Co, St Louis, MI, USA).
Male Wistar rats (90–110 days) weighing 200–240 g and male Swiss albino mice (50–70 days) weighing 25–30 g were used in the experiments. The animals were provided by the Central Biotery of the Universidade Federal de Juiz de Fora. The animals were divided into groups and kept in plastic cages (47 × 34 × 18 cm) under a 12 h light/12 h dark cycle at room temperature (22 ± 2 °C), with free access to Purina rations and water. Animal care and the experimental protocol followed the principles and guidelines suggested by the Brazilian College of Animal Experimentation (COBEA) and were approved by the local ethical committee.
3.4. Acute Toxicity
Groups of ten mice received oral doses of 0.5, 1, 1.5, 2 and 3 g/kg of ethanol extract from A. muricata, while the control group received the vehicle (saline). The groups were observed for 48 h and mortality at end of this period was recorded for each group . The LD50 (50% lethal dose) was determined by probit test using a log plot of percentage death versus dose . The determination of LD50 served to define the doses used in experiments of pharmacological activities.
3.5. Acetic Acid-Induced Writhing Response in Mice
Antinociceptive activity was evaluated using the test of abdominal writhing induced by acetic acid in mice . Animals were divided into groups of eight mice. Control mice received an i.p. injection of acetic acid 0.6% (0.25 mL) and 10 min later the writhes were counted over a period of 20 min. One group of mice received indomethacin (10 mg/kg) by the per oral route (p.o.) as a reference compound, and the other three groups received the extract at doses (p.o.) of 100, 200 and 400 mg/kg, 1 h before the acetic acid injection.
3.6. Formalin-Induced Nociception in Mice
Mice received subplantar injections of 20 μL 2.5% formalin (in 0.9% saline) and the time of paw licking (in seconds) was determined over 0–5 min (first phase - neurogenic) and 15–30 min (second phase - inflammatory) after formalin injection . Animals (n = 8) were pretreated p.o. with extract (100, 200 or 400 mg/kg; 0.1 mL per 10 g body weight) or the reference compound, subcutaneous morphine (1 mg/kg), 1 h before administration of formalin. Control animals were treated with sterile saline (10 mL/kg).
3.7. Hot-Plate Latency Assay in Mice
Animals were placed on a hot-plate (Model LE 7406, Letica Scientific Instruments, Barcelona, Spain) heated at 55 ± 1 °C . Three groups of mice (n = 8) were treated p.o. with ethanol extract (100, 200 or 400 mg/kg; 0.1 mL per 10 g body weight); the control group received sterile saline (10 mL/kg). Measurements were performed at time 0, 30, 60 and 90 min after drug administration, with a cut-off time of 40 s to avoid lesions to the animals’ paws. The effect of pretreatment with naloxone (1 mg/kg, subcutaneously) on the analgesia produced by the ethanol extract (400 mg/kg) was determined in a separate group of animals. Morphine (1 mg/kg, subcutaneously), in the absence and presence of naloxone treatment, was used as a reference.
3.8. Carrageenan-Induced Edema in Rats
Anti-inflammatory activity was assessed on the basis of inhibition of paw edema induced by the injection of 0.1 mL of 2% carrageenan (an edematogenic agent) into the subplantar region of the right hind paw of the rat . Male Wistar rats were divided into groups of six animals which received p.o. doses of extract (100, 200 and 400 mg/kg; 0.1 mL per 10 g body weight), saline or indomethacin (10 mg/kg) 1 h before the injection of carrageenan. In the left paw, used as a control, 0.1 mL of sterile saline was injected. 1, 2, 3 and 4 h after injection of carrageenan, the measure of edema was made by the difference between the volume displaced by the right paw and the left paw using a plethysmometer (model LE 7500, Letica Scientific Instruments, Barcelona, Spain).
3.9. Carrageenan-Induced Pleurisy in Rats
Pleurisy was induced in male Wistar rats by intrapleural administration of 0.5 mL 2% carrageenan suspension in saline solution between the third and fifth ribs on the right side of the mediastinum . Extract (100, 200 and 400 mg/kg), saline or indomethacin (10 mg/kg) p.o. were given 60 min before injection of the irritant. Animals were killed 4 h after carrageenan injection, and the skin and pectoral muscles were retracted. A longitudinal incision was made between the third and fifth ribs on each side of the mediastinum. The exudate was collected and transferred to a 15 mL conical centrifuge tube and the total volume determined. A 50 μL aliquot of the exudate was used to determine the total leucocyte count in Neubauer chambers.
3.10. Calculations and Statistical Analysis
Data are expressed as mean ± s.e.m. Statistical significance was determined by one-way analysis of variance followed by the Student–Newman–Keuls test. P values below 0.05 were considered significant. The percentage of inhibition was calculated by using
The results obtained in this study confirm the ethnomedicinal use of the ethanol extract from A. muricata leaves. The data analysis supported the antinociceptive and anti-inflammatory activities, suggesting a potential for therapeutic purposes. However, further studies should be conducted to ensure its safe usage.
We are grateful to CNPq, FAPEMIG and UFJF by financial support.
References and Notes
- Di Stasi, LC; Hiruma-Lima, CA. Plantas Medicinais na Amazônia e na Mata Atlântica, 2nd ed; Editora UNESP: São Paulo, Brazil, 2002; pp. 87–112. [Google Scholar]
- Sousa, MP; Matos, MEO; Matos, FJA; Machados, MIL; Craveiro, AA. Constituintes Químicos Ativos e Propriedades Biológicas de Plantas Medicinais Brasileiras, 2nd ed; Editora UFC: Fortaleza, Brazil, 2004; pp. 281–283. [Google Scholar]
- Lorenzi, H; Matos, FJA. Plantas Medicinais No Brasil: Nativas e Exóticas, 2nd ed; Instituto Plantarum: Nova Odessa, Brazil, 2008; pp. 62–63. [Google Scholar]
- Leboeuf, M; Legueut, C; Cavé, A; Desconclois, JF; Forgacs, P; Jacquemin, H. Alkaloids of Annonaceae. XXIX. Alkaloids of Annona muricata. Planta Med 1981, 42, 37–44. [Google Scholar]
- Leboeuf, M; Cavé, A; Bhaumik, PK; Mukherjee, B; Mukherjee, R. The phytochemistry of the annonaceae. Phytochemistry 1982, 21, 2783–2813. [Google Scholar]
- Pélissler, Y; Marion, C; Kone, D; Lamaty, G; Menut, C; Besslere, JM. Volatile components of Annona muricata L. J. Essent. Oil Res 1994, 6, 411–414. [Google Scholar]
- Kossouoh, C; Moudachirou, M; Adjakidje, V; Chalchat, JC; Figuérédo, G. Essential oil chemical composition of Annona muricata L. leaves from Benin. J. Essent. Oil Res 2007, 19, 307–309. [Google Scholar]
- Rupprecht, JK; Hui, YH; McLaughlin, JL. Annonaceous acetogenins: a review. J. Nat. Prod 1990, 53, 237–278. [Google Scholar]
- Cavé, A; Figadère, B; Laurens, A; Cortes, D. Acetogenins from Annonaceae. Fortschr. Chem. Org. Naturst 1997, 70, 281–288. [Google Scholar]
- Wu, FE; Gu, ZM; Zeng, L; Zhao, GX; Zhang, Y; McLaughlin, JL; Sastrodihardjo, S. Two new cytotoxic monotetrahydrofuran Annonaceous acetogenins, annomuricins A and B, from the leaves of Annona muricata. J. Nat. Prod 1995, 58, 830–836. [Google Scholar]
- Wu, FE; Zeng, L; Gu, ZM; Zhao, GX; Zhang, Y; Schwedler, JT; McLaughlin, JL; Sastrodihardjo, S. Muricatocins A and B, two new bioactive monotetrahydrofuran Annonaceous acetogenins from the leaves of Annona muricata. J. Nat. Prod 1995, 58, 902–908. [Google Scholar]
- Wu, FE; Zeng, L; Gu, ZM; Zhao, GX; Zhang, Y; Schwedler, JT; McLaughlin, JL; Sastrodihardjo, S. New bioactive monotetrahydrofuran Annonaceous acetogenins, annomuricin C and muricatocin C, from the leaves of Annona muricata. J. Nat. Prod 1995, 58, 909–915. [Google Scholar]
- Wu, FE; Zhao, GX; Zeng, L; Zhang, Y; Schwedler, JT; McLaughlin, JL; Sastrodihardjo, S. Additional bioactive acetogenins, annomutacin and (2,4-trans and cis)-10R-annonacin-A-ones, from the leaves of Annona muricata. J. Nat. Prod 1995, 58, 1430–1437. [Google Scholar]
- Zeng, L; Wu, FE; Oberlies, NH; McLaughlin, JL; Sastrodihadjo, S. Five new monotetrahydrofuran ring acetogenins from the leaves of Annona muricata. J. Nat. Prod 1996, 59, 1035–1042. [Google Scholar]
- Kim, GS; Zeng, L; Alali, F; Rogers, LL; Wu, FE; McLaughlin, JL; Sastrodihardjo, S. Two new mono-tetrahydrofuran ring acetogenins, annomuricin E and muricapentocin, from the leaves of Annona muricata. J. Nat. Prod 1998, 61, 432–436. [Google Scholar]
- Kim, GS; Zeng, L; Alali, F; Rogers, LL; Wu, FE; Sastrodihardjo, S; McLaughlin, JL. Muricoreacin and murihexocin C, mono-tetrahydrofuran acetogenins, from the leaves of Annona muricata. Phytochem 1998, 49, 565–571. [Google Scholar]
- Chang, FR; Liaw, CC; Lin, CY; Chou, CJ; Chiu, HF; Wu, YC. New adjacent Bis-tetrahydrofuran Annonaceous acetogenins from Annona muricata. Planta Med 2003, 69, 241–246. [Google Scholar]
- Luna, JS; Carvalho, JM; Lima, MR; Bieber, LW; Bento, ES; Franck, X; Sant'ana, AX. Acetogenins in Annona muricata L. (Annonaceae) leaves are potent molluscicides. Nat. Prod. Res 2006, 20, 253–257. [Google Scholar]
- Baskar, R; Rajeswari, V; Kumar, TS. In vitro antioxidant studies in leaves of Annona species. Indian J. Exp. Biol 2007, 45, 480–485. [Google Scholar]
- Santos, AF; Sant'Ana, AEG. Molluscicidal properties of some species of Annona. Phytomedicine 2001, 8, 115–120. [Google Scholar]
- Deraedt, R; Jouquey, S; Delevallée, F; Flahaut, M. Release of prostaglandins E and F in an algogenic reaction and its inhibition. Eur. J. Pharmacol 1980, 51, 17–24. [Google Scholar]
- Hunskaar, S; Hole, K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 1987, 30, 103–114. [Google Scholar]
- Shibata, M; Ohkubo, T; Takahashi, H; Inoki, R. Modified formalin test; characteristic biphasic pain response. Pain 1989, 38, 347–352. [Google Scholar]
- Yaksh, TL; Rudy, TA. Studies on direct spinal action of narcotics in production of analgesia in rat. J. Pharmacol. Exp. Ther 1977, 202, 411–428. [Google Scholar]
- Sousa, OV; Del-Vechio-Vieira, G; Amaral, MPH; Pinho, JJRG; Yamamoto, CH; Alves, MS. Efeitos antinociceptivo e antiinflamatório do extrato etanólico das folhas de Duguetia lanceolata St. Hil. (Annonaceae). Lat. Am. J. Pharm 2008, 27, 398–402. [Google Scholar]
- Sousa, OV; Del-Vechio-Vieira, G; Kaplan, MAC. Propriedades analgésica e antiinflamatória do extrato metanólico de folhas de Annona coriacea Mart. (Annonaceae). Lat. Am. J. Pharm 2007, 26, 872–877. [Google Scholar]
- Di Rosa, M; Giroud, JP; Willoughby, DA. Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J. Pathol 1971, 104, 15–29. [Google Scholar]
- Seibert, K; Zhang, Y; Leahy, K; Hauser, S; Masferrer, J; Perkins, W; Lee, L; Isakson, P. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. USA 1994, 91, 12013–12017. [Google Scholar]
- Nantel, F; Denis, D; Gordon, R; Northey, A; Cirino, M; Metters, KM; Chan, CC. Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation. Br. J. Pharmacol 1999, 128, 853–859. [Google Scholar]
- Stochla, K; Maślinśki, S. Carrageenan-induced oedema in the rat paw-histamine participation. Agents Actions 1982, 12, 201–202. [Google Scholar]
- Hwang, SB; Lam, MH; Li, CL; Shen, TY. Release of platelet activation factor and its involvement in the first phase of carrageenin-induced rat foot edema. Eur. J. Pharmacol 1986, 120, 33–41. [Google Scholar]
- De Campos, RO; Alves, RV; Kyle, DJ; Chakravarty, S; Mavunkel, BJ; Calixto, JB. Antioedematogenic and antinociceptive actions of NPC 18521, a novel bradykinin B2 receptor antagonist. Eur. J. Pharmacol 1996, 316, 277–286. [Google Scholar]
- Gilligan, JP; Lovato, SJ; Erion, MD; Jeng, AY. Modulation of carrageenan-induced hind paw edema by substance P. Inflammation 1994, 18, 285–292. [Google Scholar]
- Ammendola, G; Di Rosa, M; Sorrentino, L. Leucocyte migration and lysosomal enzymes release in rat carrageenin pleurisy. Agents Actions 1975, 5, 250–255. [Google Scholar]
- Almeida, AP; Bayer, BM; Horakova, Z; Beaven, MA. Influence of indomethacin and other anti-inflammatory drugs on mobilization and production of neutrophils: studies with carrageenan-induced inflammation in rats. J. Pharmacol. Exp. Therap 1980, 214, 74–79. [Google Scholar]
- Capasso, F; Dunn, CJ; Yamamoto, S; Willoughby, DA; Giroud, JP. Further studies on carrageenan-induced pleurisy in rats. J. Pathol 1975, 116, 117–124. [Google Scholar]
- Vinegar, R; Truax, JF; Selph, JL. Some quantitative temporal characteristics of carrageenin-induced pleurisy in the rat. Proc. Soc. Exp. Biol. Med 1973, 143, 711–714. [Google Scholar]
- Oyemitan, IA; Iwalewa, EO; Akanmu, MA; Olugbade, TA. Antinociceptive and antiinflammatory effects of essential oil of Dennettia tripetala G. Baker (Annonaceae) in rodents. Afr. J. Tradit. Complement. Altern. Med 2008, 5, 355–362. [Google Scholar]
- Dietrich, L. A new approach to practical acute toxicity testing. Arch. Toxicol 1983, 54, 275–287. [Google Scholar]
- Litchfield, JT; Wilcoxon, F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Therap 1949, 96, 99–113. [Google Scholar]
- Collier, HDJ; Dinnin, LC; Johnson, CA; Schneider, C. The abdominal response and its suppression by analgesic drugs in the mouse. Br. J. Pharmacol. Chemother 1968, 32, 295–310. [Google Scholar]
- Eddy, NB; Leimbach, D. Synthetic analgesics. II. Dithienylbutenyl and dithienylbutilamines. J. Pharmacol. Exp. Ther 1953, 107, 385–393. [Google Scholar]
- Winter, CA; Risley, EA; Nuss, GW. Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. Med 1962, 111, 544–547. [Google Scholar]
|Group||Dose (mg/kg)||Number of writhes||Inhibition (%)|
|Control||Saline||67.62 ± 2.03||-|
|100||67.50 ± 1.74||-|
|Ethanol Extract||200||57.87 ± 1.55**||14.42|
|400||39.62 ± 1.97***||41.41|
|Indomethacin||10||18.25 ± 0.80***||73.01|
Data are mean ± s.e.m. of eight mice.**P < 0.01,***P < 0.001 vs. control group.
|Group||Dose (mg/kg)||Duration of paw licking (s)|
|First phase||Inhibition (%)||Second phase||Inhibition (%)|
|Control||Saline||86.62 ± 3.18||-||93.87 ± 2.73||-|
|100||85.87 ± 2.88||-||91.25 ± 3.07||-|
|Ethanol Extract||200||66.12 ± 1.54***||23.67||65.62 ± 1.72***||30.09|
|400||47.62 ± 2.13***||45.02||46.75 ± 1.68***||50.20|
|Morphine||1||16.25 ± 1.44***||81.24||19.37 ± 0.94***||79.36|
First phase = 0–5 min after formalin injection; second phase = 15–30 min.Data are mean = s.e.m. of eight mice.***P < 0.001 vs. control group.
|Group||Dose (mg/kg)||Time after drug administration (s)|
|0 min||30 min||60 min||90 min|
|Control||Saline||5.50 ± 0.80||6.12 ± 0.44||6.50 ± 0.50||6.75 ± 0.79|
|100||5.37 ± 0.80||6.25 ± 0.62||7.12 ± 0.29||7.25 ± 0.45|
|Ethanol Extract||200||5.50 ± 0.78||6.75 ± 0.45||8.50 ± 0.50*||9.25 ± 0.67*|
|400||5.75 ± 0.72||7.37 ± 0.80||11.87 ± 0.64***||13.25 ± 0.84***|
|Morphine||1||5.75 ± 0.65||9.62 ± 0.82**||13.75 ± 1.10***||16.87 ± 0.93***|
|Naloxone + Morphine||1 + 1||6.00 ± 0.68||7.87 ± 0.69||8.00 ± 0.46*||7.87 ± 0.55|
|Naloxone + Extract||1 + 400||5.62 ± 0.68||7.25 ± 0.75||8.75 ± 0,45**||10.87 ± 0.83**|
Data are mean ± s.e.m. of eight mice.*P < 0.05,**P < 0.01,***P < 0.001 vs. control group.
|Group||Dose (mg/kg)||Volume of hind paw (mL)|
|1 h||2 h||3 h||4 h|
|Control||Saline||0.53 ± 0.06||0.72 ± 0.05||0.95 ± 0.06||0.75 ± 0.06|
|100||0.52 ± 0.09||0.68 ± 0.06||0.80 ± 0.06||0.63 ± 0.04|
|Ethanol Extract||200||0.50 ± 0.10||0.65 ± 0.09||0.73 ± 0.06*||0.53 ± 0.03**|
|400||0.48 ± 0.07||0.60 ± 0.04||0.67 ± 0.04**||0.47 ± 0.02***|
|Indomethacin||10||0.47 ± 0.10||0.58 ± 0.05||0.62 ± 0.06**||0.43 ± 0.02***|
Data are mean ± s.e.m. of six rats.*P < 0.05,**P < 0.01,***P < 0.001 vs. control group.
© 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).